Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer

Yu-Jen Chen1, Woei-Chyn Chu, Yeong-Shiau Pu

  • 1Institute of Biomedical Engineering, National Yang-Ming University, Taipei, Taiwan.

Abstract

Insights

Washout gradient (WG) derived from dynamic contrast-enhanced MRI shows a strong association with Gleason score in prostate cancer. This parameter demonstrates good diagnostic performance in assessing tumor aggressiveness, making it a potential marker for Gleason score.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Prostate cancer (PCA) grading relies on Gleason score (GS).
  • Accurate grading is crucial for treatment decisions.
  • Non-invasive imaging biomarkers are needed to assess PCA aggressiveness.

Purpose of the Study:

  • To investigate the association between dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) parameters and prostate cancer Gleason score (GS).
  • To evaluate the utility of DCE MRI parameters, localized using apparent diffusion coefficient (ADC) maps, in assessing PCA aggressiveness.

Main Methods:

  • 43 male patients with confirmed PCA underwent 1.5 T MRI, including diffusion tensor imaging (DTI) and DCE MRI.
  • ADC maps from DTI were used to co-localize cancerous regions on DCE MRI for perfusion analysis.
  • Quantitative (Ktrans, ve, kep) and semiquantitative (peak enhancement, initial gradient, washout gradient [WG]) parameters were calculated and correlated with GS.

Main Results:

  • Washout gradient (WG) showed a significant negative correlation with GS (r = -0.75, P < 0.0001).
  • WG demonstrated good diagnostic performance for identifying aggressive PCA (GS >6), with an area under the ROC curve of 0.88.
  • A cutoff of WG = 0.125 min(-1) yielded sensitivity of 0.87 and specificity of 0.78.

Conclusions:

  • Washout gradient (WG) is significantly associated with Gleason score in prostate cancer.
  • WG exhibits strong diagnostic performance in assessing tumor aggressiveness.
  • WG shows potential as a non-invasive imaging biomarker for prostate cancer Gleason score.